Poly Cystic Ovarian Syndrome (PCOS) and Gynecological Cancers

Kanika Batra Modi
DOI: https://doi.org/10.62830/mmj1-2-17b
2024-06-15
Abstract:This review article explores the intricate link between Poly Cystic Ovarian Syndrome (PCOS) and gynaecological cancers, primarily focusing on endometrial, breast, and ovarian cancers. PCOS, marked by hormonal imbalances and metabolic disruptions, sets a milieu conducive to cancer development. The link between PCOS and endometrial cancer is particularly strong due to chronic anovulation causing an oestrogen-driven endometrial hyperplasia. Strategies to mitigate endometrial cancer risk in PCOS encompass weight management, physical activity, insulin resistance reversal, progesterone withdrawal bleeds, breastfeeding, and pregnancy. Although no definitive link is established between PCOS and breast cancer, the impact of oral contraceptive pill use on breast cancer risk in PCOS treatment requires further inquiry. Similarly, the association between PCOS and ovarian cancer is intricate, with some evidence suggesting genetic and epigenetic connections, while others indicating reduced risks. Notably, a potential link between PCOS and serous borderline tumours exists, necessitating additional research for clarity. This article highlights the importance of understanding PCOS-related cancer risks and management strategies. It underlines the need for interdisciplinary efforts to advance knowledge regarding PCOS-associated cancer risks, risk prediction models, and targeted interventions.
What problem does this paper attempt to address?